Welcome to PsychU!
Menu

Conversations Matter: The Importance Of Effective Communication Between Healthcare Providers & Care Partners Of Individuals Living With Agitation In Alzheimer’s Dementia (AAD)

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Conversations Matter: The Importance Of Effective Communication Between Healthcare Providers & Care Partners Of Individuals Living With Agitation In Alzheimer’s Dementia (AAD)

Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers (HCPs)2,3. Early identification, management and treatment of AAD has been shown to improve patient outcomes and reduce caregiver burden4,5, highlighting the importance of a strong therapeutic alliance between care partners and HCPs. In this webinar, geriatric psychiatrist, Dr. Marc Agronin, and care partner, Carrie Shaw, share their unique but complimentary perspectives on identifying and responding to agitation and navigating the shared decision-making process. Our speakers will discuss best practices for how to effectively prepare for and communicate during an appointment and what tools and resources are available for care partners. One such tool they review is the AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders6, which was designed to assist caregivers in recognizing AAD.

Click here to register for the 3:00 pm EST broadcast

References:

  1. Stella F, et al. Int J Geriatr Psychiatry. 2015;30(12):1230-1237
  2. Lindeza P, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242.
  3. Gallego-Alberto L, et al. Clin Gerontol. 2022;45(5):1295-1303.
  4. Hoe J, et al. BJPsych Open. 2017;3(1):34-40.
  5. Janzen S, et al. Am J Alzheimers Dis Other Demen. 2013;28(5):524-532
  6. Sano M, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041

Featuring

Marc E.-Agronin

Marc E. Agronin, MD

Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Carrie-Shaw

Carrie Shaw, MD

CEO & Founder of Embodied Labs

Miranda-Fisher

Miranda Fisher, PhD

Medical Science Liaison

Marc Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Miranda Fisher, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

"*" indicates required fields

Name*
Zip / Postal Code*

Choose Your Unique Login

Your username can only contain lowercase letters (a-z) and numbers. Username cannot be the same as email address.
Email*
Password*
Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

I AGREE TO THE FOLLOWING TERMS

I agree to the following terms:*
I agree to the following terms*

Event Registration

Hidden
Hidden

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS

PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.

PSYCHU MEMBERSHIP ELIGIBILITY

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.

MEMBERSHIP & REGISTRATION

Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.

ATTENDANCE LIMITATIONS

PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.

MEAL REPORTING

The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Hidden
Hidden

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders